Ingelheim, Germany (ots/PRNewswire) – Boehringer Ingelheim announced today the initiation of a new phase III clinical trial to evaluate one of its two late-stage oncology pipeline compounds for the treatment of patients with advanced ovarian cancer. The clinical study, called LUME-Ovar-1 trial, investigates the compound BIBF 1120, a novel oral anti-angiogenic agent[1], for its efficacy [...]
Tag Archive > International Consortium
Ascenion Mediates License Agreement for Novel Antibiotic against Tuberculosis
(pressebox) Munich, Germany, 20.03.2009, Ascenion announces today, that it has negotiated a licensing contract providing Inverness Medical Innovations, Inc. with worldwide, exclusive rights to a novel antibiotic for the treatment of tuberculosis. Ascenion has initiated and mediated the agreement on behalf of an international consortium of patent owners including a Russian inventor, the Leibniz Institute [...]
